Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myocardial carnitine deficiency in acute myocardial infarction.

Literature DB >> 6123712

Myocardial carnitine deficiency in acute myocardial infarction.

L G Spagnoli, M Corsi, S Villaschi, G Palmieri, F Maccari.

Abstract

Entities: Disease

Mesh：

Substances：
Carnitine

Year: 1982 PMID： 6123712 DOI： 10.1016/s0140-6736(82)92540-5

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction.

Authors: R B Singh; M A Niaz; P Agarwal; R Beegum; S S Rastogi; D S Sachan
Journal: Postgrad Med J Date: 1996-01 Impact factor: 2.401

2. L-carnitine reduces malondialdehyde concentrations in isolated rat hearts in dependence on perfusion conditions.

Authors: H Löster; U Böhm
Journal: Mol Cell Biochem Date: 2001-01 Impact factor: 3.396

3. The myocardial distribution and plasma concentration of carnitine in patients with mitral valve disease.

Authors: T Nakagawa; M Sunamori; A Suzuki
Journal: Surg Today Date: 1994 Impact factor: 2.549

Review 4. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders.

Authors: Carmen Mingorance; Rosalía Rodríguez-Rodríguez; María Luisa Justo; María Alvarez de Sotomayor; María Dolores Herrera
Journal: Vasc Health Risk Manag Date: 2011-03-28

Review 5. l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism.

Authors: K L Goa; R N Brogden
Journal: Drugs Date: 1987-07 Impact factor: 9.546

6. Additional antiischemic effects of long-term L-propionylcarnitine in anginal patients treated with conventional antianginal therapy.

Authors: G L Bartels; W J Remme; F R den Hartog; R P Wielenga; D A Kruijssen
Journal: Cardiovasc Drugs Ther Date: 1995-12 Impact factor: 3.727

7. Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: a functional, histologic, and NMR spectroscopic study.

Authors: N Corsico; A Nardone; M R Lucreziotti; L G Spagnoli; D Pesce; T Aureli; M E Di Cocco; A Miccheli; F Conti; E Arrigoni Martelli
Journal: Cardiovasc Drugs Ther Date: 1993-04 Impact factor: 3.727